Aging-associated endothelial dysfunction in humans is reversed by L-arginine

Journal of the American College of Cardiology

Volumn 28, Issue 7, 1997, Pages 1796-1804

  Chauhan, Anoop ^a,c   More, Ranjit S ^a   Mullins, Paul A ^b   Taylor, Ged ^a   Petch, Michael C ^b   Schofield, Peter M ^a  

^a PAPWORTH HOSPITAL   (United Kingdom)

^b ST MARY S HOSPITAL   (United Kingdom)

^c Laurel Cardiology   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

ACETYLCHOLINE; ARGININE; GLYCERYL TRINITRATE; PAPAVERINE;

ADULT; AGED; AGING; ANGIOCARDIOGRAPHY; ARTICLE; CLINICAL ARTICLE; CONTROLLED STUDY; CORONARY ARTERY BLOOD FLOW; FEMALE; HUMAN; INTRAARTERIAL DRUG ADMINISTRATION; MALE; PRIORITY JOURNAL; THORAX PAIN; VASCULAR ENDOTHELIUM; VASODILATATION;

ACETYLCHOLINE; ADULT; AGED; AGING; ARGININE; CORONARY CIRCULATION; CORONARY VESSELS; ENDOTHELIUM, VASCULAR; FEMALE; HUMANS; MALE; MICROCIRCULATION; MIDDLE AGED; NITROGLYCERIN; PAPAVERINE; VASODILATOR AGENTS;

EID: 0030478368     PISSN: 07351097     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0735-1097(96)00394-4     Document Type: Article

References (61)

1. Vane R, Anggard EE, Botting RM. Regulatory functions of the vascular endothelium. N Engl J Med 1990;323:27-36.
2. Furchgott RF, Zawadzki JV. The obligatory role of endothelial cells in the relaxation of arterial smooth muscle by acetylcholine. Nature 1980;288:373-6.
3. Bassenge E, Busse R. Endothelial modulation of coronary tone. Prog Cardiovasc Dis 1980;30:349-80.
4. Vanhoutte PM, Rubanyi GM, Miller M, Houston DS. Modulation of vascular smooth muscle cell concentration by the endothelium. Ann Rev Physiol 1986;48:349-80.
5. Ignarro LJ, Buga GM, Wood KS, Byrns RE, Chauduri G. Endothelium-derived relaxing factor produced and released from artery and vein is nitric oxide. Proc Natl Acad Sci USA 1987;327:524-6.
6. Palmer RM, Ferrige AG, Moncada S. Nitric oxide release accounts for the biological activity of endothelium-derived relaxing factor. Nature 1987;327:524-6.
7. Hodgson JM, Marshall JJ. Direct vasoconstriction and endothelium-dependent vasodilation: mechanisms of acetylcholine effects on coronary blood flow and arterial diameter in patients with nonstenotic coronary arteries. Circulation 1989;79:1043-51.
8. Chester AH, O'Neil GS, Moncada S, Tadjkarimi S, Yacoub MH. Low basal and stimulated release of nitric oxide in atherosclerotic epicardial coronary arteries. Lancet 1990;336:897-900.
9. Vallance P, Collier J, Moncada S. Effects of endothelium-derived nitricoxide on peripheral arterial tone in man. Lancet 1989;2:997-1000.
10. Cohen RA, Zitnay KM, Haudenschild CC, Cunningham LD. Loss of selective endothelial cell vasoactive functions caused by hypercholesterolemia in pig coronary arteries. Circ Res 1988;63:903-10.
11. Shimokawa H, Vanhoutte PM. Impaired endothelium-dependent relaxation to aggregating platelets and related vasoactive substances in porcine coronary arteries in hypercholesterolemia and atherosclerosis. Circ Res 1989;64:900-14.
12. Vita JA, Treasure CB, Nabel EG, et al. Coronary vasomotor response to acetylcholine relates to risk factors for coronary artery disease. Circulation 1990;81:491-7.
13. Zeiher AM, Drexler H, Wolschlager H, Just H. Modulation of coronary vasomotor tone in humans: progressive endothelial dysfunction with different early stages of coronary atherosclerosis. Circulation 1991;83:391-401.
14. Reddy KG, Nair RN, Sheehan HM, Hodgson JMcB. Evidence that selective endothelial dysfunction may occur in the absence of angiographic or ultrasound atherosclerosis in patients with risk factors for atherosclerosis. J Am Coll Cardiol 1994;23:833-43.
15. Schwartz SM, Gajdusek EM, Selden SC. Vascular wall growth control: the role of endothelium. Arteriosclerosis 1981;1:107-61.
16. Ross R. The pathogenesis of atherosclerosis - an update. N Engl J Med 1986;314:488-500.
17. Rae GA, Trybulec M, deNucci G, Vane JR. The anti-aggregating properties of vascular endothelium: interaction between prostacyclin and nitric oxide. Br J Pharmacol 1987;92:639-46.
18. Sneddon JM, Vane JR. Endothelium-derived relaxing factor reduces platelet adhesion to bovine endothelial cells. Proc Natl Acad Sci USA 1988;85:2800-4.
19. Lakatta EG, Yin FCP. Myocardial aging: functional alterations and related cellular mechanisms. Am J Physiol 1982;242(Heart Circ Physiol 11):H927-41.
20. Toma BS, Wangler RD, DeWitt DF, Sparks HV Jr. Effect of development on coronary vasodilator reserve in the isolated guinea pig heart. Circ Res 1985;57:538-44.
21. Mayhan WG, Faraci FM, Baumbach GL, Heistad DD. Effects of aging on responses of cerebral arterioles. Am J Physiol 1990;258(Heart Circ Physiol 27):H1138-43.
22. Egashira K, Inou T, Hirooka Y, et al. Effects of age on endothelium-dependent vasodilation of resistance coronary arteries by acetylcholine in humans. Circulation 1993;88:77-81.
23. Stewart PA, Magliocco M, Hayakawa K, et al. A quantitative analysis of blood-brain barrier ultrastructure in the aging human. Microvasc Res 1987;33:270-82.
24. Bucala RK, Tracey KJ, Cerami A. Advanced glycosylation products quench nitric oxide and mediate defective endothelium-dependent vasodilation in experimental diabetes. J Clin Invest 1991;87:434-8.
25. Moncada S, Palmer RMJ, Higgs EA. Biosynthesis of nitric oxide from L-arginine. A pathway for the regulation of cell function and communication. Biochem Pharmacol 1989;38:1709-15.
26. Rubanyi GM. Reversal of hypercholesterolemia-induced endothelial dysfunction by L-arginine. Circulation 1991;83:1118-20.
27. Wilson RF, Laughlin DE, Ackell PM, et al. Transluminal, subselective measurement of coronary artery blood flow velocity and vasodilator reserve in man. Circulation 1985;72:82-92.
28. Sibley DH, Millar HD, Hartley CJ, Whitlow PL. Subselective measurement of coronary blood flow velocity using a steerable Doppler catheter. J Am Coll Cardiol 1986;8:1332-40.
29. Chauhan A, Mullins PA, Petch MC, Schofield PM. Is coronary flow reserve in response to papaverine really normal in syndrome X? Circulation 1994;89:1998-2004.
30. Mullins PA, Chauhan A, Sharples L, et al. Impairment of coronary flow reserve in orthotopic cardiac transplant recipients with minor coronary occlusive disease. Br Heart J 1992;68:266-71.
31. Chauhan A, Mullins P, Taylor G, Petch M, Schofield P. The effect of hyperventilation and mental stress on coronary blood flow in syndrome X patients. Br Heart J 1993;69:516-24.
32. Drexler H, Zeiher AM, Wollschaeger H, Meinertz T, Just H, Bonzel T. Flow-dependent coronary artery dilation in humans. Circulation 1989;80:466-74.
33. Cox DA, Vita JA, Treasure CB, et al. Atherosclerosis impairs flow-mediated dilation of coronary arteries in humans. Circulation 1989;80:458-65.
34. Glagov S, Weisenberg E, Zarkins CK, Stankunavicius R, Koletis GK. Compensatory enlargement of human atherosclerotic coronary arteries. N Engl J Med 1987;316:1371-5.
35. McPherson DD, Hiratzka LF, Lamberth WC, et al. Delineation of the extent of coronary atherosclerosis by high-frequency epicardial echocardiography. N Engl J Med 1987;316:304-9.
36. Zeiher AM, Drexler H, Wollschlager H, Just H. Endothelial dysfunction of the coronary microvasculature is associated with impaired coronary blood flow regulation in patients with early atherosclerosis. Circulation 1991;84:1984-92.
37. Treasure CB, Vita JA, Cox DA, et al. Endothelium-dependent dilation of the coronary microvasculature is impaired in dilated cardiomyopathy. Circulation 1990;81:772-9.
38. Zeiher AM, Drexler H, Saurbier B, Just H. Endothelium-mediated coronary blood flow modulation in humans: effects of age, atherosclerosis, hypercholesterolemia, and hypertension. J Clin Invest 1993;92:652-62.
39. Cooke JP, Andon NA, Girered XJ, Hirsh AT, Creager MA. Arginine restores cholinergic relaxation of hypercholesterolemic rabbit thoracic aorta. Circulation 1991;83:1057-62.
40. Drexler H, Zeiher AM, Meinzer K, Just H. Correction of endothelial dysfunction in coronary microcirculation of hypercholesterolemic patients by L-arginine. Lancet 1991;338:1546-50.
41. Drexler H, Fischell TA, Pinto FJ, et al. Effect of L-arginine on coronary endothelial function in cardiac transplant recipients: relation to vessel wall morphology. Circulation 1994;89:1615-23.
42. Weyrich AS, Ma X-L, Lefer AM. The role of L-arginine in ameliorating reperfusion injury after myocardial ischemia in the cat. Circulation 1992;86:279-88.
43. Girered XJ, Hirch AT, Cooke JP, Dzau VJ, Creager MA. L-Arginine augments endothelium-dependent vasodilation in cholesterol-fed rabbits. Circ Res 1990;67:1301-8.
44. Rossitch E Jr, Alexander E III, Black P, Cooke JP. L-Arginine normalizes endothelial function in cerebral vessels from hypercholesterolemic rabbits. J Clin Invest 1991;87:1295-9.
45. Chowienczyk PJ, Watts GF, Cockcroft JR, Brett SE, Ritter JM. Sex differences in endothelial function in normal and hypercholesterolaemic subjects. Lancet 1994;344:305-6.
46. Czernin J, Sun K, Brunken R, Bottchler M, Phelps M, Schelbert H. Effect of acute and long term smoking on myocardial blood flow and reserve. Circulation 1995;91:2891-7.
47. Quillen JE, Rossen JD, Oskarsson HJ, Minor RL, Lopez AG, Winniford MD. Acute effects of cigarette smoking on coronary circulation: constriction of epicardial and resistance vessels. J Am Coll Cardiol 1993;22:642-7.
48. Zeiher MA, Schachinger V, Minners J. Long-term cigarette smoking impairs endothelium-dependent coronary arterial vasodilator function. Circulation 1995;92:1094-100.
49. Nitenberg A, Antony I, Foult JM. Acetylcholine induced coronary vasoconstriction in young heavy smokers with normal coronary angiographic findings. Am J Med 1993;95:71-7.
50. Egashira K, Inou T, Hirooka Y, et al. Impaired coronary blood flow response to acetylcholine in patients with coronary risk factors and proximal atherosclerotic lesions. J Clin Invest 1993;91:29-37.
51. Kuo L, Davis MJ, Cannon S, Chilian WM. Pathophysiological consequences of atherosclerosis extend into the coronary microcirculation: restoration of endothelium-dependent responses by L-arginine. Circ Res 1992;70:465-76.
52. Bogle RG, Coade SB, Moncada S, Pearson JD, Mann GE. Bradykinin and ATP stimulate L-arginine uptake and nitric oxide release in vascular endothelial cells. Biochem Biophys Res Commun 1991;180:926-32.
53. Murohara T, Kugiyama K, Ohgushi M, Sugiyama S, Yasue H. Cigarette smoke extract contracts isolated porcine coronary arteries by superoxide anion-mediated degradation of EDRF. Am J Physiol 1994;266:H874-80.
54. Ohara Y, Peterson TE, Harrison DG. Hypercholesterolemia increases endothelial superoxide anion production. J Clin Invest 1993;91:2546-51.
55. Hogan JC, Lewis MJ, Henderson AH. In vivo EDRF activity influences platelet function. Br J Pharmacol 1988;94:1020-2.
56. Ludmer PL, Selwyn AP, Shook TL, et al. Paradoxical vasoconstriction induced by acetylcholine in atherosclerotic coronary arteries. N Engl J Med 1986;315:1046-51.
57. Floyd JC, Fajans SS, Conn JW, Knopf RF, Rull J. Stimulation of insulin secretion by amino acids. J Clin Invest 1966;9:1487-502.
58. Creager MA, Liang CS, Coffman JD. Beta-adrenergic-mediated vasodilator response to insulin in the human forearm. J Pharmacol Exp Ther 1985;235:709-14.
59. Creager MA, Gallagher SJ, Girerd XJ, Coleman SM, Dzau VJ, Cooke JP. L-Arginine improves endothelium-dependent vasodilation in hypercholesterolemic humans. J Clin Invest 1992;90:1248-53.
60. Yanagisawa M, Kurihara H, Kimura S, et al. A novel potent vasoconstrictor peptide produced by vascular endothelial cells. Nature 1988;332:411-5.
61. Cooke JP, Rossitch Jr E, Andon NA, Loscalzo J, Dzau V. Flow activates an endothelium potassium channel to release an endogenous nitrovasodilator. J Clin Invest 1991;88:1663-71.